In 2021, a significant link between B-cell and myeloid-cell signalling was revealed using two scRNA-seq approaches, while CCL8+ cycling B cells/CCR5+ T-cell interactions were identified as a potential antitumoral mechanism in advanced CRC tumors (57). This evidence concerns the gene CCL8 and colorectal carcinoma.